SEDIA BIOSCIENCES CORPORATION

Basic Information

4900 NE 122ND AVE
PORTLAND, OR, 97230-1049

http://www.sediabio.com

Company Profile

n/a

Additional Details

Field Value
DUNS: 016504083
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 11


  1. Development and Commercialization of an Innovative Rapid HIV-1 Incidence Assay

    Amount: $195,490.00

    DESCRIPTION (provided by applicant): The objective of this project is to develop a commercially viable point of care Rapid HIV-1 Incidence Assay and establish its suitability for determination of rece ...

    SBIR Phase I 2014 Department of Health and Human Services
  2. Novel Single Well Avidity EIA to Determine Recency of HIV-1 Infections

    Amount: $1,000,000.00

    DESCRIPTION (provided by applicant): The objectives of this project are to develop a commercial single well HIV-1 Limiting Antigen Avidity EIA, developed in Phase I as a research tool, and establish i ...

    SBIR Phase II 2014 Department of Health and Human Services
  3. Novel Single Well Avidity EIA to Determine Recency of HIV-1 Infections

    Amount: $194,123.00

    DESCRIPTION (provided by applicant): The objective of this project is to develop a commercially viable single well HIV-1 Limiting Antigen Avidity EIA and establish its suitability fo determination of ...

    SBIR Phase I 2012 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government